DANAHER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235.5 USD | -0.36% |
|
-1.73% | +1.80% |
| Apr. 17 | AdaptHealth Names Suzanne Foster as CEO | MT |
| Apr. 17 | AdaptHealth Names Suzanne Foster CEO | DJ |
Financials (USD)
| Sales 2024 * | 24.03B | Sales 2025 * | 26.1B | Capitalization | 175B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.48B | Net income 2025 * | 5.38B | EV / Sales 2024 * | 7.52 x |
| Net Debt 2024 * | 5.55B | Net cash position 2025 * | 668M | EV / Sales 2025 * | 6.68 x |
| P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
32.4
x | Employees | 62,000 |
| Yield 2024 * |
0.45% | Yield 2025 * |
0.48% | Free-Float | 74.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danaher Corporation
More recommendations
More press releases
More news
| 1 day | -0.36% | ||
| 1 week | -1.85% | ||
| Current month | -5.69% | ||
| 1 month | -7.18% | ||
| 3 months | +1.93% | ||
| 6 months | +13.61% | ||
| Current year | +1.80% |
1 week
230.74
243.26
1 month
230.74256.51
Current year
222.53259.00
1 year
182.09269.61
3 years
182.09333.96
5 years
119.60333.96
10 years
70.12333.96
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 09-12-31 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
Alan Spoon
BRD | Director/Board Member | 72 | 99-06-30 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.99% | 18 M€ | +1.40% | - | |
| 3.77% | 2 M€ | +2.32% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 236.4 | -1.27% | 4,261,041 |
| 24-04-17 | 239.4 | -0.40% | 2,988,576 |
| 24-04-16 | 240.3 | +0.28% | 3,225,524 |
| 24-04-15 | 239.7 | -0.12% | 2,824,169 |
| 24-04-12 | 240 | -1.66% | 2,684,915 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotes
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-04-23
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
236.4
USD
Average target price
264.9
USD
Spread / Average Target
+12.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.80% | 175B | |
| +2.64% | 207B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B | |
| +3.97% | 26.09B |
- Stock Market
- Equities
- DHR Stock
